Rare primary liver malignant tumor
Tian-hao WANG,Zhi-gang PAN,Zheng-gang REN
DOI: https://doi.org/10.3969/j.issn.1672-8467.2009.02.020
2009-01-01
Abstract:Objective To improve the diagnosis and treatment of rare primary liver malignant tumor. Methods A retrospective analysis was made on 40 cases of rare liver malignant tumor, which were surgically resected in our hospital and had been confirmed by pathology. Results Rare liver malignant tumor accounted for 0. 74% in all primary liver malignant tumor (40/5 487) in the same period,including 12 pathological kinds : angiosarcoma (6 cases), leiomyosarcoma (5 cases), malignant fibrous histiocytoma (5 cases), rhabdomyosarcoma (1 case) , undifferentiated embryonal sarcoma (1 case) ,cystadenocarcinoma (4 cases), epithelioid hemangioendothelioma (1 case) , lymphoma (5 cases), squamous cell cancer (2 cases) , adenosquamous cancer (3 cases), carnoid cancer (3 cases), carcinosarcoma (4 cases). Twenty-one of them had no clinical presentation, 12 of them complained right upper quadrant pain, 2 of them presented jaundice, 1 of them complained fever. About 32. 5% of them was positive of HBsAg (13/40), 1 case of rhabdomyosarcoma AFP was elevated, 4 cases of liver cystadenocarcinoma or squmous cell cancer or adenosquamous carcinoma CA199 were elevated . No patients was diagnosed directedly by image before operation. Three cases of primary hepaticlymohoma patients were diagonsed hemangioma or chronic infection. Three cases of primary liver sracoma were diagnosed chronic infection, hemangioma or cystadenoma. Two cases primary squamous cell cancer was diagonosed liver tuberculosis. One case of carnoid was diagnosed fibrous luminar malignant tumor. One cystadenocarcinoma was diagnosed liver cyst. Other patients was diagnosed liver maligant tumor . As to prognosis, 4 cases of primary liver lymphoma and 2 cases liver cystadenocarcinoma survived over five years. Fifty percent of primary liver sarcoma survived over one year, but at most 25% primary liver sarcoma survived over 3 years. All liver squamous cell cancer and liver adnenosquamous carcinoma died in one year after surgery. Conclusions Rare primary liver malignant tumor has no specific clinical presentation or serum tumor markers. It was difficult to differentiated between them and other liver tumor such as hepatocellular carcinoma or some benign liver tumor, so they are very difficult to be diagnosed before operation. The mainstay therpy is surgical resection, and the prognosis of liver cystadenocarcinoma and primary hepatic lymphoma is better,while the prognosis of liver squamous cell carcinoma and adenosquamous carcinoma is the worst.